{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:10:35Z","timestamp":1753877435787,"version":"3.41.2"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Medical Faculty of Heidelberg University"},{"DOI":"10.13039\/100008658","name":"German Cancer Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008658","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012353","name":"German Cancer Consortium","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012353","id-type":"DOI","asserted-by":"publisher"}]},{"name":"German Federal Ministry of Education and Research"},{"name":"German Federal Ministry of Health"},{"name":"Ministry of Science"},{"name":"Research and the Arts of the State of Baden-W\u00fcrttemberg"},{"DOI":"10.13039\/501100005972","name":"German Cancer Aid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007311","name":"German Childhood Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007311","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>High-grade glioma (HGG) of the spinal cord constitutes rare tumors in the pediatric population. Knowledge of the molecular profile of this pediatric HGG (pedHGG) subgroup is limited and the clinical outcome is poor. Therefore, the aim of this study is to provide more profound investigations of molecular characteristics and clinical features of these tumors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Between January 2015 and October 2023, 17 spinal tumors with HGG histology were analyzed by the Individualized Therapy For Relapsed Malignancies in Childhood (INFORM) precision oncology registry. Comprehensive molecular profiling (including next-generation sequencing approaches and DNA methylation analysis) was performed. Clinical data provided by the treating centers were evaluated regarding treatment approaches and outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Subgroup classification based on DNA methylation analysis revealed molecular HGG subgroups in 12\/17 cases, while 2\/17 were classified as molecular low-grade glioma (LGG) and 3\/17 were not unequivocally classifiable. Typical genetic alterations described in pedHGG usually presenting at other localizations were also present in the counterparts located in the spinal cohort. Alterations that might serve as a promising target for personalized therapy approaches were identified in a subset of tumors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>With this cohort of 12 molecularly confirmed spinal pedHGG cases, we provide a compilation of genomic as well as clinical features of this rare subgroup, contributing to a better understanding and eventually to future treatment approaches.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/noajnl\/vdae185","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T13:13:16Z","timestamp":1731071596000},"source":"Crossref","is-referenced-by-count":0,"title":["Pediatric spinal high-grade glioma in the pediatric precision oncology registry INFORM: Identification of potential therapeutic targets"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3967-2264","authenticated-orcid":false,"given":"Elke","family":"Pfaff","sequence":"first","affiliation":[{"name":"Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital , Heidelberg ,","place":["Germany"]},{"name":"German Cancer Research Center (DKFZ) , Heidelberg ,","place":["Germany"]},{"name":"National Center for Tumor Diseases (NCT), NCT Heidelberg, DKFZ and Heidelberg University Hospital , Heidelberg ,\u00a0","place":["Germany"]},{"name":"Division of Pediatric Glioma Research, Hopp Children\u2019s Cancer Center Heidelberg (KiTZ) , Heidelberg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathrin","family":"Schramm","sequence":"additional","affiliation":[{"name":"German Cancer Research Center (DKFZ) , Heidelberg ,","place":["Germany"]},{"name":"National Center for Tumor Diseases (NCT), NCT Heidelberg, DKFZ and Heidelberg University Hospital , Heidelberg ,\u00a0","place":["Germany"]},{"name":"Division of Pediatric Glioma Research, Hopp Children\u2019s Cancer Center Heidelberg (KiTZ) , Heidelberg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjam","family":"Blattner-Johnson","sequence":"additional","affiliation":[{"name":"German Cancer Research Center (DKFZ) , Heidelberg ,","place":["Germany"]},{"name":"National Center for Tumor Diseases (NCT), NCT Heidelberg, DKFZ and Heidelberg University Hospital , Heidelberg ,\u00a0","place":["Germany"]},{"name":"Division of Pediatric Glioma Research, Hopp Children\u2019s Cancer Center Heidelberg (KiTZ) , Heidelberg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara C","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital , Heidelberg ,","place":["Germany"]},{"name":"German Cancer Research Center (DKFZ) , Heidelberg ,","place":["Germany"]},{"name":"National Center for Tumor Diseases (NCT), NCT Heidelberg, DKFZ and Heidelberg University Hospital , Heidelberg ,\u00a0","place":["Germany"]},{"name":"Division of Pediatric Glioma Research, Hopp Children\u2019s Cancer Center Heidelberg (KiTZ) , Heidelberg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Stark","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital , Heidelberg ,","place":["Germany"]},{"name":"German Cancer Research Center (DKFZ) , Heidelberg ,","place":["Germany"]},{"name":"National Center for Tumor Diseases (NCT), NCT Heidelberg, DKFZ and Heidelberg University Hospital , Heidelberg ,\u00a0","place":["Germany"]},{"name":"Division of Pediatric Glioma Research, Hopp Children\u2019s Cancer Center Heidelberg (KiTZ) , Heidelberg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gnana Prakash","family":"Balasubramanian","sequence":"additional","affiliation":[{"name":"Division of Pediatric Neurooncology, Hopp Children\u2019s Cancer Center Heidelberg (KiTZ) , Heidelberg,","place":["Germany"]},{"name":"German Cancer Research Center (DKFZ) , Heidelberg ,","place":["Germany"]},{"name":"National Center for Tumor Diseases (NCT), NCT Heidelberg, DKFZ and Heidelberg University Hospital , Heidelberg ,\u00a0","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Previti","sequence":"additional","affiliation":[{"name":"Division of Pediatric Neurooncology, Hopp Children\u2019s Cancer Center Heidelberg (KiTZ) , Heidelberg,","place":["Germany"]},{"name":"German Cancer Research Center (DKFZ) , Heidelberg ,","place":["Germany"]},{"name":"National Center for Tumor Diseases (NCT), NCT Heidelberg, DKFZ and Heidelberg University Hospital , Heidelberg ,\u00a0","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J","family":"Autry","sequence":"additional","affiliation":[{"name":"Division of Pediatric Neurooncology, Hopp Children\u2019s Cancer Center Heidelberg (KiTZ) , Heidelberg,","place":["Germany"]},{"name":"German Cancer Research Center (DKFZ) , Heidelberg ,","place":["Germany"]},{"name":"National Center for Tumor Diseases (NCT), NCT Heidelberg, DKFZ and Heidelberg University Hospital , Heidelberg ,\u00a0","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Fiesel","sequence":"additional","affiliation":[{"name":"Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) , Heidelberg ,","place":["Germany"]},{"name":"Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital , Heidelberg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5441-1962","authenticated-orcid":false,"given":"Felix","family":"Sahm","sequence":"additional","affiliation":[{"name":"Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) , Heidelberg ,","place":["Germany"]},{"name":"Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital , Heidelberg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Reuss","sequence":"additional","affiliation":[{"name":"Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) , Heidelberg ,","place":["Germany"]},{"name":"Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital , Heidelberg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5863-540X","authenticated-orcid":false,"given":"Andreas","family":"von Deimling","sequence":"additional","affiliation":[{"name":"Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) , Heidelberg ,","place":["Germany"]},{"name":"Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital , Heidelberg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelis M","family":"van Tilburg","sequence":"additional","affiliation":[{"name":"Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) , Heidelberg ,","place":["Germany"]},{"name":"Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital , Heidelberg ,","place":["Germany"]},{"name":"German Cancer Research Center (DKFZ) , Heidelberg ,","place":["Germany"]},{"name":"National Center for Tumor Diseases (NCT), NCT Heidelberg, DKFZ and Heidelberg University Hospital , Heidelberg ,\u00a0","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3562-6121","authenticated-orcid":false,"given":"Kristian W","family":"Pajtler","sequence":"additional","affiliation":[{"name":"Division of Pediatric Neurooncology, Hopp Children\u2019s Cancer Center Heidelberg (KiTZ) , Heidelberg,","place":["Germany"]},{"name":"Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital , Heidelberg ,","place":["Germany"]},{"name":"German Cancer Research Center (DKFZ) , Heidelberg ,","place":["Germany"]},{"name":"National Center for Tumor Diseases (NCT), NCT Heidelberg, DKFZ and Heidelberg University Hospital , Heidelberg ,\u00a0","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7267-1052","authenticated-orcid":false,"given":"Till","family":"Milde","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, University Hospital Jena, Friedrich Schiller University Jena , Jena,","place":["Germany"]},{"name":"Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) , Heidelberg ,","place":["Germany"]},{"name":"Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital , Heidelberg ,","place":["Germany"]},{"name":"German Cancer Research Center (DKFZ) , Heidelberg ,","place":["Germany"]},{"name":"National Center for Tumor Diseases (NCT), NCT Heidelberg, DKFZ and Heidelberg University Hospital , Heidelberg ,\u00a0","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uta","family":"Dirksen","sequence":"additional","affiliation":[{"name":"National Center for Tumor diseases (NCT) partner site Essen, University Hospital Essen , Essen,","place":["Germany"]},{"name":"German Cancer Consortium (DKTK) partner site Essen, University Hospital Essen , Essen,","place":["Germany"]},{"name":"Pediatrics III, West German Cancer Centre Essen, University Hospital Essen, University of Duisburg-Essen , Essen,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christof M","family":"Kramm","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology and Oncology, Department of Child and Adolescent Health, University Medical Center G\u00f6ttingen , G\u00f6ttingen,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 O","family":"von Bueren","sequence":"additional","affiliation":[{"name":"Cansearch Research Platform for Pediatric Oncology and Hematology, Faculty of Medicine, Department of Pediatrics, Gynecology and Obstetrics, University of Geneva , Geneva ,","place":["Switzerland"]},{"name":"Department of Pediatrics, Gynecology and Obstetrics, Division of Pediatric Hematology and Oncology, University Hospital of Geneva , Geneva ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica C","family":"Munthe-Kaas","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology and Hematology, Oslo University Hospital , Oslo,","place":["Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3931-4125","authenticated-orcid":false,"given":"Ingrid","family":"\u00d8ra","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology-Oncology, Sk\u00e5ne University Hospital, Clinical Sciences IKVL, Lund University , Lund ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5447-5322","authenticated-orcid":false,"given":"Stefan M","family":"Pfister","sequence":"additional","affiliation":[{"name":"Division of Pediatric Neurooncology, Hopp Children\u2019s Cancer Center Heidelberg (KiTZ) , Heidelberg,","place":["Germany"]},{"name":"Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital , Heidelberg ,","place":["Germany"]},{"name":"German Cancer Research Center (DKFZ) , Heidelberg ,","place":["Germany"]},{"name":"National Center for Tumor Diseases (NCT), NCT Heidelberg, DKFZ and Heidelberg University Hospital , Heidelberg ,\u00a0","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaf","family":"Witt","sequence":"additional","affiliation":[{"name":"Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) , Heidelberg ,","place":["Germany"]},{"name":"Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital , Heidelberg ,","place":["Germany"]},{"name":"German Cancer Research Center (DKFZ) , Heidelberg ,","place":["Germany"]},{"name":"National Center for Tumor Diseases (NCT), NCT Heidelberg, DKFZ and Heidelberg University Hospital , Heidelberg ,\u00a0","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2036-5141","authenticated-orcid":false,"given":"David T W","family":"Jones","sequence":"additional","affiliation":[{"name":"German Cancer Research Center (DKFZ) , Heidelberg ,","place":["Germany"]},{"name":"National Center for Tumor Diseases (NCT), NCT Heidelberg, DKFZ and Heidelberg University Hospital , Heidelberg ,\u00a0","place":["Germany"]},{"name":"Division of Pediatric Glioma Research, Hopp Children\u2019s Cancer Center Heidelberg (KiTZ) , Heidelberg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,11,8]]},"reference":[{"issue":"4","key":"2025013113502289600_CIT0001","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/s41591-023-02255-1","article-title":"Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology","volume":"29","author":"Sturm","year":"2023","journal-title":"Nat Med."},{"issue":"Supplement_4","key":"2025013113502289600_CIT0002","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noad149","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2016\u20132020","volume":"25","author":"Ostrom","year":"2023","journal-title":"Neuro-Oncol."},{"issue":"1","key":"2025013113502289600_CIT0003","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00381-020-04722-3","article-title":"Pediatric primary high-grade spinal glioma: a National Cancer Database analysis of current patterns in treatment and outcomes","volume":"37","author":"Nunna","year":"2021","journal-title":"Child\u2019s Nerv Syst"},{"issue":"1","key":"2025013113502289600_CIT0004","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11060-011-0718-y","article-title":"Pediatric high grade glioma of the spinal cord: results of the HIT-GBM database","volume":"107","author":"Wolff","year":"2012","journal-title":"J Neurooncol."},{"issue":"5","key":"2025013113502289600_CIT0005","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000353135","article-title":"Analysis of risk factors and survival in pediatric high-grade spinal cord astrocytoma: a population-based study","volume":"48","author":"Lam","year":"2012","journal-title":"Pediatr Neurosurg."},{"issue":"6","key":"2025013113502289600_CIT0006","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3171\/2017.1.PEDS16528","article-title":"Pediatric spinal cord astrocytomas: a retrospective study of 348 patients from the SEER database","volume":"19","author":"Luksik","year":"2017","journal-title":"J Neurosurg Pediatr."},{"issue":"2","key":"2025013113502289600_CIT0007","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3171\/2016.8.PEDS1631","article-title":"A systematic review of overall survival in pediatric primary glioblastoma multiforme of the spinal cord","volume":"19","author":"Konar","year":"2017","journal-title":"J Neurosurg Pediatr."},{"issue":"8","key":"2025013113502289600_CIT0008","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro-Oncol."},{"issue":"4","key":"2025013113502289600_CIT0009","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ccell.2017.08.017","article-title":"Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma","volume":"32","author":"Mackay","year":"2017","journal-title":"Cancer cell"},{"issue":"1","key":"2025013113502289600_CIT0010","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s40478-018-0614-1","article-title":"Transcriptomic and epigenetic profiling of \u2018diffuse midline gliomas, H3 K27M-mutant\u2019 discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location","volume":"6","author":"Castel","year":"2018","journal-title":"Acta Neuropathol Commun."},{"issue":"8","key":"2025013113502289600_CIT0011","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/neuonc\/nox021","article-title":"Diffuse intrinsic pontine gliomas-current management and new biologic insights. Is there a glimmer of hope","volume":"19","author":"Cohen","year":"2017","journal-title":"Neuro-Oncol."},{"key":"2025013113502289600_CIT0012","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejca.2016.06.009","article-title":"Next-generation personalised medicine for high-risk paediatric cancer patients\u2013The INFORM pilot study","volume":"65","author":"Worst","year":"2016","journal-title":"Eur J cancer (Oxford, England: 1990)."},{"issue":"11","key":"2025013113502289600_CIT0013","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1158\/2159-8290.CD-21-0094","article-title":"The pediatric precision oncology INFORM Registry: clinical outcome and benefit for patients with very high-evidence targets","volume":"11","author":"van Tilburg","year":"2021","journal-title":"Cancer Discov."},{"key":"2025013113502289600_CIT0014","doi-asserted-by":"crossref","first-page":"e2300015","DOI":"10.1200\/PO.23.00015","article-title":"Outcome of children and adolescents with relapsed\/refractory\/progressive malignancies treated with molecularly informed targeted drugs in the pediatric precision oncology registry INFORM","volume":"7","author":"Heipertz","year":"2023","journal-title":"JCO Precision Oncology."},{"key":"2025013113502289600_CIT0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejca.2019.03.019","article-title":"Brainstem biopsy in pediatric diffuse intrinsic pontine glioma in the era of precision medicine: the INFORM study experience","volume":"114","author":"Pfaff","year":"2019","journal-title":"Eur J cancer (Oxford, England: 1990)."},{"issue":"7697","key":"2025013113502289600_CIT0016","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature26000","article-title":"DNA methylation-based classification of central nervous system tumours","volume":"555","author":"Capper","year":"2018","journal-title":"Nature."},{"issue":"1","key":"2025013113502289600_CIT0017","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12859-019-2851-0","article-title":"TelomereHunter\u2013in silico estimation of telomere content and composition from cancer genomes","volume":"20","author":"Feuerbach","year":"2019","journal-title":"BMC Bioinf."},{"issue":"1","key":"2025013113502289600_CIT0018","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/s41467-019-13824-9","article-title":"Genomic footprints of activated telomere maintenance mechanisms in cancer","volume":"11","author":"Sieverling","year":"2020","journal-title":"Nat Commun."},{"issue":"1","key":"2025013113502289600_CIT0019","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.1038\/s41467-021-25708-y","article-title":"Radiation-induced gliomas represent H3-\/IDH-wild type pediatric gliomas with recurrent PDGFRA amplification and loss of CDKN2A\/B","volume":"12","author":"Deng","year":"2021","journal-title":"Nat Commun."},{"issue":"5","key":"2025013113502289600_CIT0020","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.cell.2017.09.048","article-title":"Comprehensive analysis of hypermutation in human cancer","volume":"171","author":"Campbell","year":"2017","journal-title":"Cell."},{"issue":"2","key":"2025013113502289600_CIT0021","doi-asserted-by":"crossref","first-page":"100387","DOI":"10.1016\/j.modpat.2023.100387","article-title":"PATZ1-rearranged tumors of the central nervous system: characterization of a pediatric series of seven cases","volume":"37","author":"Rossi","year":"2024","journal-title":"Mod Pathol."},{"issue":"5","key":"2025013113502289600_CIT0022","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00401-021-02354-8","article-title":"PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum","volume":"142","author":"Alhalabi","year":"2021","journal-title":"Acta Neuropathol."},{"issue":"1","key":"2025013113502289600_CIT0023","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/bpa.12619","article-title":"EWSR1-PATZ1 gene fusion may define a new glioneuronal tumor entity","volume":"29","author":"Siegfried","year":"2019","journal-title":"Brain Pathol (Zurich, Switzerland)."},{"issue":"11","key":"2025013113502289600_CIT0024","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/s41379-019-0301-1","article-title":"Clinical, pathological, and genomic features of EWSR1-PATZ1 fusion sarcoma","volume":"32","author":"Bridge","year":"2019","journal-title":"Mod Pathol."},{"issue":"2","key":"2025013113502289600_CIT0025","doi-asserted-by":"crossref","first-page":"100400","DOI":"10.1016\/j.modpat.2023.100400","article-title":"Sarcomas harboring EWSR1::PATZ1 fusions: a clinicopathologic study of 17 cases","volume":"37","author":"Dehner","year":"2024","journal-title":"Mod Pathol."},{"issue":"2","key":"2025013113502289600_CIT0026","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/PAS.0000000000001183","article-title":"Spindle and round cell sarcoma with EWSR1-PATZ1 gene fusion: a sarcoma with polyphenotypic differentiation","volume":"43","author":"Chougule","year":"2019","journal-title":"Am J Surg Pathol."},{"key":"2025013113502289600_CIT0027","first-page":"101","article-title":"Updates on WHO classification for small round cell tumors: Ewing sarcoma vs. everything else","volume-title":"Hum Pathol.","author":"Dehner","year":"2024"},{"issue":"3","key":"2025013113502289600_CIT0028","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00401-015-1463-7","article-title":"High frequency of H3F3A (K27M) mutations characterizes pediatric and adult high-grade gliomas of the spinal cord","volume":"130","author":"Gessi","year":"2015","journal-title":"Acta Neuropathol."},{"issue":"5","key":"2025013113502289600_CIT0029","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/ng.2950","article-title":"Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma","volume":"46","author":"Fontebasso","year":"2014","journal-title":"Nat Genet."},{"issue":"6","key":"2025013113502289600_CIT0030","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/neuonc\/noab274","article-title":"Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors","volume":"24","author":"Doz","year":"2022","journal-title":"Neuro-Oncol."},{"issue":"10","key":"2025013113502289600_CIT0031","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1093\/neuonc\/noac087","article-title":"Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG)","volume":"24","author":"Desai","year":"2022","journal-title":"Neuro-Oncol."},{"issue":"19","key":"2025013113502289600_CIT0032","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1200\/JCO.2016.66.6552","article-title":"Immune checkpoint inhibition for hypermutant glioblastoma multiforme resulting from germline biallelic mismatch repair deficiency","volume":"34","author":"Bouffet","year":"2016","journal-title":"J Clin Oncol."},{"issue":"23","key":"2025013113502289600_CIT0033","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.1158\/1078-0432.CCR-23-0411","article-title":"Efficacy of nivolumab in pediatric cancers with high mutation burden and mismatch-repair deficiency","volume":"29","author":"Das","year":"2023","journal-title":"Clin Cancer Res."},{"issue":"3","key":"2025013113502289600_CIT0034","doi-asserted-by":"crossref","first-page":"e30836","DOI":"10.1002\/pbc.30836","article-title":"Feasibility and antitumour activity of the FGFR inhibitor erdafitnib in three paediatric CNS tumour patients","volume":"71","author":"Stepien","year":"2024","journal-title":"Pediatr Blood & Cancer."},{"key":"2025013113502289600_CIT0035","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1200\/PO.20.00444","article-title":"Debio1347, an oral FGFR inhibitor: results from a single-center study in pediatric patients with recurrent or refractory FGFR-altered gliomas","volume":"5","author":"Farouk Sait","year":"2021","journal-title":"JCO Preci Oncol."},{"issue":"9","key":"2025013113502289600_CIT0036","doi-asserted-by":"crossref","first-page":"966","DOI":"10.6004\/jnccn.2022.7030","article-title":"Response to selpercatinib in a patient with recurrent glioblastoma and RET amplification","volume":"20","author":"Czech","year":"2022","journal-title":"J Natl Compr Cancer Netw."}],"container-title":["Neuro-Oncology Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/noa\/advance-article-pdf\/doi\/10.1093\/noajnl\/vdae185\/60541372\/vdae185.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/noa\/article-pdf\/7\/1\/vdae185\/60541372\/vdae185.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/noa\/article-pdf\/7\/1\/vdae185\/60541372\/vdae185.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T13:51:02Z","timestamp":1738331462000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/noa\/article\/doi\/10.1093\/noajnl\/vdae185\/7887542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,8]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/noajnl\/vdae185","relation":{},"ISSN":["2632-2498"],"issn-type":[{"type":"electronic","value":"2632-2498"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2024,11,8]]},"article-number":"vdae185"}}